AC Immune (ACIU) EBITDA (2015 - 2025)
AC Immune (ACIU) posted EBITDA of -$17.6 million for the quarter ended Dec 31, 2025, compared with -$20.84 million a year earlier.
Powered by 
Analysis
AC Immune (ACIU) EBITDA (2015 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, AC Immune's EBITDA came in at -$81.93 million.
- In prior years, AC Immune's EBITDA was -$57.85 million in the year ended Dec 31, 2024, -$57.85 million in the year ended Dec 31, 2023, -$72.39 million in the year ended Dec 31, 2022 and -$84.39 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly EBITDA since the quarter ended Sep 30, 2024.
- According to Business Quant data, EBITDA for the three prior quarters was -$19.78 million (quarter ended Sep 30, 2025), -$22.98 million (quarter ended Jun 30, 2025) and -$21.14 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | AC Immune | 265.55 Mn | 265.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -17.60 Mn |
| Sep 30, 2025 | -19.78 Mn |
| Jun 30, 2025 | -22.98 Mn |
| Mar 31, 2025 | -21.14 Mn |
| Dec 31, 2024 | -20.84 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Jun 30, 2024 | -22.76 Mn |
| Mar 31, 2024 | -22.55 Mn |
| Dec 31, 2023 | -3.52 Mn |
| Sep 30, 2023 | -17.04 Mn |
| Jun 30, 2023 | -18.51 Mn |
| Mar 31, 2023 | -18.53 Mn |
| Dec 31, 2022 | -18.93 Mn |
| Sep 30, 2022 | -13.49 Mn |
| Jun 30, 2022 | -20.17 Mn |
| Mar 31, 2022 | -19.89 Mn |
| Dec 31, 2021 | -24.19 Mn |
| Sep 30, 2021 | -21.55 Mn |
| Jun 30, 2021 | -19.97 Mn |
| Mar 31, 2021 | -18.59 Mn |
API Access
AC Immune EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();